

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.18555574 |
| 2 | vocalization behavior (GO:0071625) | 5.28142571 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.24234048 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.23646849 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19004545 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.09363126 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.07025438 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.06651720 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.05945101 |
| 10 | glutamate secretion (GO:0014047) | 4.93657166 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.82714702 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.74170135 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.70891096 |
| 14 | protein localization to synapse (GO:0035418) | 4.63925933 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.63737389 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.47040515 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.45388789 |
| 18 | synaptic transmission, glutamatergic (GO:0035249) | 4.43763738 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.31645708 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.28256727 |
| 21 | neuron-neuron synaptic transmission (GO:0007270) | 4.24876921 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.19489192 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.14445224 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.12554078 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 4.12064341 |
| 26 | exploration behavior (GO:0035640) | 4.09733607 |
| 27 | axon ensheathment in central nervous system (GO:0032291) | 3.93895360 |
| 28 | central nervous system myelination (GO:0022010) | 3.93895360 |
| 29 | neuron recognition (GO:0008038) | 3.89697928 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.87595289 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.86556039 |
| 32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.85977665 |
| 33 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.83584247 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.81270662 |
| 35 | long-term memory (GO:0007616) | 3.80480405 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.78602370 |
| 37 | neurotransmitter transport (GO:0006836) | 3.77902767 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.77353181 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.73604929 |
| 40 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.73535910 |
| 41 | transmission of nerve impulse (GO:0019226) | 3.73271416 |
| 42 | cellular potassium ion homeostasis (GO:0030007) | 3.70497387 |
| 43 | synaptic vesicle endocytosis (GO:0048488) | 3.68342888 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.65877302 |
| 45 | proline transport (GO:0015824) | 3.64067443 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.61355353 |
| 47 | positive regulation of membrane potential (GO:0045838) | 3.57650740 |
| 48 | L-amino acid import (GO:0043092) | 3.56245894 |
| 49 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.55136600 |
| 50 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.51218377 |
| 51 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.50425734 |
| 52 | regulation of neurotransmitter levels (GO:0001505) | 3.46357191 |
| 53 | positive regulation of synapse maturation (GO:0090129) | 3.43840049 |
| 54 | presynaptic membrane assembly (GO:0097105) | 3.41822575 |
| 55 | activation of protein kinase A activity (GO:0034199) | 3.38958460 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.38089726 |
| 57 | long-term synaptic potentiation (GO:0060291) | 3.36243507 |
| 58 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35687278 |
| 59 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.35414562 |
| 60 | neuromuscular process controlling posture (GO:0050884) | 3.32939912 |
| 61 | regulation of neurotransmitter secretion (GO:0046928) | 3.32929238 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32865089 |
| 63 | postsynaptic membrane organization (GO:0001941) | 3.31187006 |
| 64 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.31125659 |
| 65 | behavioral fear response (GO:0001662) | 3.29992569 |
| 66 | behavioral defense response (GO:0002209) | 3.29992569 |
| 67 | axonal fasciculation (GO:0007413) | 3.29446108 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.28892719 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.26281613 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.26143764 |
| 71 | membrane hyperpolarization (GO:0060081) | 3.23706703 |
| 72 | presynaptic membrane organization (GO:0097090) | 3.23124373 |
| 73 | neuromuscular process controlling balance (GO:0050885) | 3.22227790 |
| 74 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.20456223 |
| 75 | response to histamine (GO:0034776) | 3.18715035 |
| 76 | fear response (GO:0042596) | 3.17810420 |
| 77 | potassium ion import (GO:0010107) | 3.17074947 |
| 78 | * membrane depolarization (GO:0051899) | 3.14085203 |
| 79 | mating behavior (GO:0007617) | 3.14007343 |
| 80 | synapse assembly (GO:0007416) | 3.11691274 |
| 81 | serotonin metabolic process (GO:0042428) | 3.11253847 |
| 82 | potassium ion homeostasis (GO:0055075) | 3.11238888 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.10854556 |
| 84 | prepulse inhibition (GO:0060134) | 3.08933519 |
| 85 | auditory behavior (GO:0031223) | 3.08234428 |
| 86 | sodium ion export (GO:0071436) | 3.06736959 |
| 87 | response to auditory stimulus (GO:0010996) | 3.05197967 |
| 88 | synaptic transmission (GO:0007268) | 3.04424123 |
| 89 | cerebellar granule cell differentiation (GO:0021707) | 3.04369767 |
| 90 | amino acid import (GO:0043090) | 3.03798127 |
| 91 | glycine transport (GO:0015816) | 3.03022169 |
| 92 | * membrane depolarization during action potential (GO:0086010) | 3.02035043 |
| 93 | learning (GO:0007612) | 3.01253783 |
| 94 | neurotransmitter uptake (GO:0001504) | 3.00771806 |
| 95 | vesicle transport along microtubule (GO:0047496) | 3.00426788 |
| 96 | neuronal ion channel clustering (GO:0045161) | 3.00336437 |
| 97 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.00055446 |
| 98 | dendrite morphogenesis (GO:0048813) | 2.99827691 |
| 99 | adult walking behavior (GO:0007628) | 2.99228071 |
| 100 | righting reflex (GO:0060013) | 2.98067149 |
| 101 | C4-dicarboxylate transport (GO:0015740) | 2.98055823 |
| 102 | regulation of synaptic transmission (GO:0050804) | 2.96822647 |
| 103 | behavioral response to cocaine (GO:0048148) | 2.96757197 |
| 104 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.95952475 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 2.92914461 |
| 106 | primary amino compound metabolic process (GO:1901160) | 2.92889205 |
| 107 | positive regulation of neurotransmitter transport (GO:0051590) | 2.92587413 |
| 108 | neuromuscular synaptic transmission (GO:0007274) | 2.89914355 |
| 109 | striatum development (GO:0021756) | 2.89384806 |
| 110 | regulation of respiratory system process (GO:0044065) | 2.89254432 |
| 111 | detection of calcium ion (GO:0005513) | 2.88730200 |
| 112 | startle response (GO:0001964) | 2.88115407 |
| 113 | positive regulation of dendritic spine development (GO:0060999) | 2.87753198 |
| 114 | innervation (GO:0060384) | 2.87538376 |
| 115 | synapse organization (GO:0050808) | 2.86806169 |
| 116 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.86579729 |
| 117 | suckling behavior (GO:0001967) | 2.86305855 |
| 118 | mechanosensory behavior (GO:0007638) | 2.85462848 |
| 119 | regulation of synapse maturation (GO:0090128) | 2.83381193 |
| 120 | phosphorelay signal transduction system (GO:0000160) | 2.83181324 |
| 121 | glycosphingolipid biosynthetic process (GO:0006688) | 2.80877210 |
| 122 | cellular sodium ion homeostasis (GO:0006883) | 2.80496427 |
| 123 | acidic amino acid transport (GO:0015800) | 2.77689577 |
| 124 | regulation of dendritic spine development (GO:0060998) | 2.77401261 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.74439097 |
| 126 | regulation of neurotransmitter uptake (GO:0051580) | 2.73492950 |
| 127 | neuronal action potential (GO:0019228) | 2.73424402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.80336635 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82683999 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08123244 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99843549 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.97311480 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65715209 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59447933 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59447933 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55366390 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52287576 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49474731 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46560064 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45555100 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42265714 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41118285 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.37496030 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37131006 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27737658 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19634096 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.16130389 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14972907 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.11994419 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09167367 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.05355425 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03240089 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94182655 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93857905 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88377661 |
| 29 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82732357 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81854522 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80918170 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77225225 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70294081 |
| 34 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67732547 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63994058 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55571580 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52049833 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50972270 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50880711 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47857800 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39512759 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38847035 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38286755 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37635043 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36258865 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35969229 |
| 47 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35100736 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34583560 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33964401 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33615019 |
| 51 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33309450 |
| 52 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33183746 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31569457 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31347023 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29901628 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29536432 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29161148 |
| 58 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27524376 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26112112 |
| 60 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26091232 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25612234 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24560949 |
| 63 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21882487 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.19267887 |
| 65 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17954279 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17458989 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15495035 |
| 68 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15223377 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15107162 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15073314 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14608280 |
| 72 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14608280 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14154789 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13836684 |
| 75 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13231997 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.12633618 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12400673 |
| 78 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12216989 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09982309 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08726836 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07936276 |
| 82 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06334902 |
| 83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05444740 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05312221 |
| 85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04768210 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04493169 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03834987 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03816893 |
| 89 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03621708 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03394487 |
| 91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03328913 |
| 92 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02109026 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01980894 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01866370 |
| 95 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00772791 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00053585 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99446317 |
| 98 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99252927 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98402486 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98305765 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98124063 |
| 102 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98019889 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97533962 |
| 104 | JUN_21703547_ChIP-Seq_K562_Human | 0.97077909 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95843682 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 0.93741996 |
| 107 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93192486 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91911884 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90488075 |
| 110 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89908075 |
| 111 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89111535 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89109111 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88605803 |
| 114 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87991604 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87465100 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87465100 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86707058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.06935956 |
| 2 | MP0003880_abnormal_central_pattern | 4.94592558 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.05165620 |
| 4 | MP0009745_abnormal_behavioral_response | 3.46858376 |
| 5 | MP0004270_analgesia | 3.43237972 |
| 6 | MP0002064_seizures | 3.26423503 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.26390944 |
| 8 | MP0009046_muscle_twitch | 3.19604256 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.05765303 |
| 10 | MP0002822_catalepsy | 2.90559200 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.87532006 |
| 12 | * MP0002272_abnormal_nervous_system | 2.71111774 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.70751400 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.58961184 |
| 15 | MP0001486_abnormal_startle_reflex | 2.53987478 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.53915668 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.44034566 |
| 18 | MP0002736_abnormal_nociception_after | 2.41159949 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.39864821 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.20533452 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.10504252 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.02645219 |
| 23 | MP0001970_abnormal_pain_threshold | 1.98470920 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.93941157 |
| 25 | MP0005386_behavior/neurological_phenoty | 1.86599553 |
| 26 | MP0004924_abnormal_behavior | 1.86599553 |
| 27 | MP0006276_abnormal_autonomic_nervous | 1.83192272 |
| 28 | MP0002184_abnormal_innervation | 1.82353130 |
| 29 | MP0008569_lethality_at_weaning | 1.81486295 |
| 30 | MP0003329_amyloid_beta_deposits | 1.80973069 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.78902420 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.77306933 |
| 33 | MP0002909_abnormal_adrenal_gland | 1.75882988 |
| 34 | MP0000778_abnormal_nervous_system | 1.72122459 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.62295968 |
| 36 | MP0000955_abnormal_spinal_cord | 1.60277948 |
| 37 | MP0001529_abnormal_vocalization | 1.55361086 |
| 38 | MP0003879_abnormal_hair_cell | 1.54219481 |
| 39 | MP0001984_abnormal_olfaction | 1.52380779 |
| 40 | MP0004885_abnormal_endolymph | 1.50737016 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.47235794 |
| 42 | MP0004858_abnormal_nervous_system | 1.44917627 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.44028727 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.42402725 |
| 45 | MP0004142_abnormal_muscle_tone | 1.42351545 |
| 46 | MP0002102_abnormal_ear_morphology | 1.41882038 |
| 47 | MP0003787_abnormal_imprinting | 1.38981712 |
| 48 | MP0003122_maternal_imprinting | 1.38144664 |
| 49 | MP0001905_abnormal_dopamine_level | 1.32407135 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.30598933 |
| 51 | MP0003633_abnormal_nervous_system | 1.30273067 |
| 52 | MP0001188_hyperpigmentation | 1.24159313 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.23998937 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.21477816 |
| 55 | MP0003631_nervous_system_phenotype | 1.11514792 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.11380467 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.10774915 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.10099643 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.10064179 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 1.09566244 |
| 61 | MP0002229_neurodegeneration | 1.08116227 |
| 62 | MP0002152_abnormal_brain_morphology | 1.06307971 |
| 63 | MP0004742_abnormal_vestibular_system | 1.04605841 |
| 64 | MP0008872_abnormal_physiological_respon | 0.96137897 |
| 65 | MP0003634_abnormal_glial_cell | 0.95834108 |
| 66 | MP0000920_abnormal_myelination | 0.93801871 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.93723394 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.93373744 |
| 69 | MP0001963_abnormal_hearing_physiology | 0.89665587 |
| 70 | MP0004085_abnormal_heartbeat | 0.89029783 |
| 71 | MP0000751_myopathy | 0.88622099 |
| 72 | MP0001177_atelectasis | 0.87370151 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 0.87139977 |
| 74 | MP0003121_genomic_imprinting | 0.87117162 |
| 75 | MP0004147_increased_porphyrin_level | 0.86264908 |
| 76 | MP0003690_abnormal_glial_cell | 0.85949539 |
| 77 | MP0005535_abnormal_body_temperature | 0.85778954 |
| 78 | MP0004133_heterotaxia | 0.85273745 |
| 79 | MP0003632_abnormal_nervous_system | 0.84953274 |
| 80 | MP0003283_abnormal_digestive_organ | 0.82465209 |
| 81 | MP0005409_darkened_coat_color | 0.81166753 |
| 82 | MP0002752_abnormal_somatic_nervous | 0.80801008 |
| 83 | MP0002638_abnormal_pupillary_reflex | 0.80662775 |
| 84 | MP0000604_amyloidosis | 0.76769750 |
| 85 | * MP0008874_decreased_physiological_sensi | 0.76597542 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.76071500 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 0.75386357 |
| 88 | MP0002876_abnormal_thyroid_physiology | 0.73347720 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.71293202 |
| 90 | MP0005499_abnormal_olfactory_system | 0.71293202 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.70244551 |
| 92 | MP0002090_abnormal_vision | 0.69734416 |
| 93 | MP0004043_abnormal_pH_regulation | 0.68584856 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.68208973 |
| 95 | MP0000427_abnormal_hair_cycle | 0.66415077 |
| 96 | MP0005171_absent_coat_pigmentation | 0.66386563 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.65871150 |
| 98 | MP0001664_abnormal_digestion | 0.62869243 |
| 99 | MP0000383_abnormal_hair_follicle | 0.61210247 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.61184458 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.59946256 |
| 102 | MP0003137_abnormal_impulse_conducting | 0.59017112 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.56546284 |
| 104 | MP0003075_altered_response_to | 0.55385518 |
| 105 | * MP0001943_abnormal_respiration | 0.54932235 |
| 106 | MP0004484_altered_response_of | 0.54783163 |
| 107 | MP0003123_paternal_imprinting | 0.53865509 |
| 108 | MP0005253_abnormal_eye_physiology | 0.53809860 |
| 109 | MP0002082_postnatal_lethality | 0.53638429 |
| 110 | MP0010770_preweaning_lethality | 0.53638429 |
| 111 | MP0001756_abnormal_urination | 0.53620687 |
| 112 | MP0000026_abnormal_inner_ear | 0.53533595 |
| 113 | MP0010769_abnormal_survival | 0.53510535 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.52070295 |
| 115 | MP0005195_abnormal_posterior_eye | 0.50584465 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.50362118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.91019401 |
| 2 | Myokymia (HP:0002411) | 6.29924542 |
| 3 | Focal seizures (HP:0007359) | 5.71946086 |
| 4 | Visual hallucinations (HP:0002367) | 5.22299696 |
| 5 | Atonic seizures (HP:0010819) | 5.05347705 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.83322548 |
| 7 | Febrile seizures (HP:0002373) | 4.69691123 |
| 8 | Absence seizures (HP:0002121) | 4.48425661 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.20669860 |
| 10 | Dialeptic seizures (HP:0011146) | 4.08882521 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.01469511 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.73762238 |
| 13 | Broad-based gait (HP:0002136) | 3.73589668 |
| 14 | Action tremor (HP:0002345) | 3.69247193 |
| 15 | Hyperventilation (HP:0002883) | 3.55863348 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.27592628 |
| 17 | Truncal ataxia (HP:0002078) | 3.08131218 |
| 18 | Depression (HP:0000716) | 3.07958664 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.06679050 |
| 20 | Ankle clonus (HP:0011448) | 3.06117126 |
| 21 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.04228374 |
| 22 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.03697498 |
| 23 | Dysmetria (HP:0001310) | 3.01588852 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.98429199 |
| 25 | Anxiety (HP:0000739) | 2.98401910 |
| 26 | Pancreatic fibrosis (HP:0100732) | 2.94085017 |
| 27 | Amblyopia (HP:0000646) | 2.93784156 |
| 28 | Postural instability (HP:0002172) | 2.91533123 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.86468503 |
| 30 | Chronic hepatic failure (HP:0100626) | 2.85021058 |
| 31 | Nephronophthisis (HP:0000090) | 2.84640416 |
| 32 | Drooling (HP:0002307) | 2.83169602 |
| 33 | Excessive salivation (HP:0003781) | 2.83169602 |
| 34 | Abnormal eating behavior (HP:0100738) | 2.80911706 |
| 35 | Scanning speech (HP:0002168) | 2.79123472 |
| 36 | Progressive inability to walk (HP:0002505) | 2.77720717 |
| 37 | Abnormal drinking behavior (HP:0030082) | 2.77251492 |
| 38 | Polydipsia (HP:0001959) | 2.77251492 |
| 39 | * Poor eye contact (HP:0000817) | 2.76080613 |
| 40 | True hermaphroditism (HP:0010459) | 2.74998749 |
| 41 | Pancreatic cysts (HP:0001737) | 2.74510700 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.73984393 |
| 43 | Abnormality of midbrain morphology (HP:0002418) | 2.73749116 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 2.73749116 |
| 45 | Mutism (HP:0002300) | 2.69983049 |
| 46 | Spastic gait (HP:0002064) | 2.65745853 |
| 47 | Abnormality of the corticospinal tract (HP:0002492) | 2.65661296 |
| 48 | Papilledema (HP:0001085) | 2.65653926 |
| 49 | Tubular atrophy (HP:0000092) | 2.63282723 |
| 50 | Epileptiform EEG discharges (HP:0011182) | 2.61814546 |
| 51 | Hemiparesis (HP:0001269) | 2.61270148 |
| 52 | Absent speech (HP:0001344) | 2.60615007 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.58333271 |
| 54 | Termporal pattern (HP:0011008) | 2.57585357 |
| 55 | Insidious onset (HP:0003587) | 2.57585357 |
| 56 | Genetic anticipation (HP:0003743) | 2.57546248 |
| 57 | * Abnormal social behavior (HP:0012433) | 2.55968636 |
| 58 | * Impaired social interactions (HP:0000735) | 2.55968636 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52539204 |
| 60 | Limb dystonia (HP:0002451) | 2.51643069 |
| 61 | Diplopia (HP:0000651) | 2.50363255 |
| 62 | Abnormality of binocular vision (HP:0011514) | 2.50363255 |
| 63 | Urinary urgency (HP:0000012) | 2.50216581 |
| 64 | Akinesia (HP:0002304) | 2.43804417 |
| 65 | Intention tremor (HP:0002080) | 2.43295370 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.40550969 |
| 67 | Bradykinesia (HP:0002067) | 2.39935299 |
| 68 | Occipital encephalocele (HP:0002085) | 2.35978997 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.35324704 |
| 70 | Agitation (HP:0000713) | 2.29222344 |
| 71 | Torticollis (HP:0000473) | 2.28265295 |
| 72 | Pheochromocytoma (HP:0002666) | 2.26165278 |
| 73 | Abnormality of the renal medulla (HP:0100957) | 2.23814353 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.23426259 |
| 75 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.22774842 |
| 76 | Status epilepticus (HP:0002133) | 2.22483807 |
| 77 | Blue irides (HP:0000635) | 2.22466307 |
| 78 | Cystic liver disease (HP:0006706) | 2.22382491 |
| 79 | Hemiplegia (HP:0002301) | 2.21255718 |
| 80 | Inability to walk (HP:0002540) | 2.20855044 |
| 81 | Hypoventilation (HP:0002791) | 2.19528113 |
| 82 | Stereotypic behavior (HP:0000733) | 2.16919468 |
| 83 | Cerebral hypomyelination (HP:0006808) | 2.16578062 |
| 84 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.15801733 |
| 85 | Lower limb muscle weakness (HP:0007340) | 2.15280995 |
| 86 | Abnormality of the lower motor neuron (HP:0002366) | 2.14855428 |
| 87 | Generalized myoclonic seizures (HP:0002123) | 2.13911073 |
| 88 | Congenital primary aphakia (HP:0007707) | 2.11456947 |
| 89 | Polyphagia (HP:0002591) | 2.11428437 |
| 90 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.10350423 |
| 91 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.10350423 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.10243700 |
| 93 | Focal dystonia (HP:0004373) | 2.10060389 |
| 94 | Increased circulating renin level (HP:0000848) | 2.06170448 |
| 95 | Gait ataxia (HP:0002066) | 2.02162923 |
| 96 | Abnormal ciliary motility (HP:0012262) | 1.99700113 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 1.98501417 |
| 98 | Gait imbalance (HP:0002141) | 1.97891032 |
| 99 | Type II lissencephaly (HP:0007260) | 1.97798174 |
| 100 | Protruding tongue (HP:0010808) | 1.97684618 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.96384655 |
| 102 | Psychosis (HP:0000709) | 1.96176541 |
| 103 | Impaired vibratory sensation (HP:0002495) | 1.94767197 |
| 104 | Spastic tetraparesis (HP:0001285) | 1.93818299 |
| 105 | Bile duct proliferation (HP:0001408) | 1.92990378 |
| 106 | Abnormal biliary tract physiology (HP:0012439) | 1.92990378 |
| 107 | Dysmetric saccades (HP:0000641) | 1.92648631 |
| 108 | Sleep apnea (HP:0010535) | 1.91901951 |
| 109 | Abnormality of salivation (HP:0100755) | 1.91713328 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 1.91705345 |
| 111 | Nephrogenic diabetes insipidus (HP:0009806) | 1.91276873 |
| 112 | Diminished movement (HP:0002374) | 1.87504558 |
| 113 | Craniofacial dystonia (HP:0012179) | 1.87285927 |
| 114 | Failure to thrive in infancy (HP:0001531) | 1.87138042 |
| 115 | Abnormality of the renal cortex (HP:0011035) | 1.86291404 |
| 116 | Megalencephaly (HP:0001355) | 1.85648720 |
| 117 | Hypomagnesemia (HP:0002917) | 1.84861581 |
| 118 | Abnormal EKG (HP:0003115) | 1.83234207 |
| 119 | Polyuria (HP:0000103) | 1.82012455 |
| 120 | Resting tremor (HP:0002322) | 1.81390232 |
| 121 | Rigidity (HP:0002063) | 1.78879424 |
| 122 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78116162 |
| 123 | Specific learning disability (HP:0001328) | 1.77996606 |
| 124 | Abnormality of saccadic eye movements (HP:0000570) | 1.77328397 |
| 125 | Insomnia (HP:0100785) | 1.77312419 |
| 126 | Abnormality of the labia minora (HP:0012880) | 1.76925574 |
| 127 | Genital tract atresia (HP:0001827) | 1.76070554 |
| 128 | Bundle branch block (HP:0011710) | 1.75314796 |
| 129 | Retinal dysplasia (HP:0007973) | 1.72229590 |
| 130 | Incomplete penetrance (HP:0003829) | 1.72147710 |
| 131 | Inappropriate behavior (HP:0000719) | 1.71726205 |
| 132 | Delusions (HP:0000746) | 1.71640759 |
| 133 | Generalized hypopigmentation of hair (HP:0011358) | 1.71352859 |
| 134 | Amyotrophic lateral sclerosis (HP:0007354) | 1.71307036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.89644976 |
| 2 | EPHA4 | 4.31054246 |
| 3 | MAP3K9 | 3.44847578 |
| 4 | MAP3K4 | 3.20158439 |
| 5 | MARK1 | 2.96423483 |
| 6 | FRK | 2.95628605 |
| 7 | MAP2K7 | 2.65195318 |
| 8 | MINK1 | 2.47877191 |
| 9 | CASK | 2.41064757 |
| 10 | NTRK2 | 2.34905240 |
| 11 | NTRK1 | 2.14086742 |
| 12 | PRKD3 | 1.98043900 |
| 13 | DAPK2 | 1.97336352 |
| 14 | PAK6 | 1.93817397 |
| 15 | RIPK4 | 1.88078843 |
| 16 | MAP2K4 | 1.87827028 |
| 17 | PNCK | 1.84579532 |
| 18 | MAP3K12 | 1.77211420 |
| 19 | KSR2 | 1.77166976 |
| 20 | CAMKK1 | 1.60327595 |
| 21 | TNIK | 1.57920772 |
| 22 | CDK5 | 1.50799860 |
| 23 | GRK5 | 1.46706331 |
| 24 | MAPK13 | 1.44800171 |
| 25 | PLK2 | 1.42517335 |
| 26 | CAMKK2 | 1.37952851 |
| 27 | KSR1 | 1.32383740 |
| 28 | MAP4K2 | 1.32320331 |
| 29 | UHMK1 | 1.29122627 |
| 30 | FES | 1.28332751 |
| 31 | ARAF | 1.26803477 |
| 32 | SIK2 | 1.25382946 |
| 33 | CDK19 | 1.23072970 |
| 34 | PRKCG | 1.22189255 |
| 35 | FGFR2 | 1.21906308 |
| 36 | DAPK1 | 1.21220135 |
| 37 | WNK4 | 1.19208541 |
| 38 | STK38 | 1.18987361 |
| 39 | CAMK2A | 1.13182181 |
| 40 | ADRBK2 | 1.12431189 |
| 41 | MAP3K2 | 1.11585317 |
| 42 | PRPF4B | 1.04331301 |
| 43 | SGK494 | 1.03783013 |
| 44 | SGK223 | 1.03783013 |
| 45 | GRK1 | 1.03426620 |
| 46 | CAMK2B | 1.01792764 |
| 47 | PRKCH | 1.01436826 |
| 48 | OXSR1 | 1.00146378 |
| 49 | CSNK1G1 | 0.98429749 |
| 50 | MAP3K13 | 0.98165918 |
| 51 | BMPR1B | 0.97296053 |
| 52 | PHKG2 | 0.94442691 |
| 53 | PHKG1 | 0.94442691 |
| 54 | CSNK1G3 | 0.92627344 |
| 55 | CSNK1A1L | 0.89908134 |
| 56 | STK11 | 0.85420385 |
| 57 | TYRO3 | 0.85205123 |
| 58 | CAMK1 | 0.84818791 |
| 59 | BMPR2 | 0.83832615 |
| 60 | PAK3 | 0.81690919 |
| 61 | SGK2 | 0.81193016 |
| 62 | CDK18 | 0.79918246 |
| 63 | CDK15 | 0.78949365 |
| 64 | CDK14 | 0.78635193 |
| 65 | CSNK1G2 | 0.78545989 |
| 66 | STK38L | 0.77978431 |
| 67 | SGK1 | 0.76942567 |
| 68 | RET | 0.75735537 |
| 69 | LIMK1 | 0.73899088 |
| 70 | PINK1 | 0.73517292 |
| 71 | DYRK1A | 0.71553057 |
| 72 | TNK2 | 0.69397542 |
| 73 | CAMK2D | 0.69194920 |
| 74 | LATS2 | 0.68664128 |
| 75 | PRKCE | 0.68576532 |
| 76 | MARK2 | 0.68235900 |
| 77 | CDK11A | 0.67410855 |
| 78 | PTK2B | 0.66874244 |
| 79 | WNK1 | 0.66621990 |
| 80 | MAP2K6 | 0.63105835 |
| 81 | CAMK1G | 0.62063055 |
| 82 | CAMK2G | 0.60672241 |
| 83 | SGK3 | 0.59477172 |
| 84 | NEK6 | 0.58674161 |
| 85 | ADRBK1 | 0.58445273 |
| 86 | RAF1 | 0.58051414 |
| 87 | CDC42BPA | 0.57926062 |
| 88 | ALK | 0.57042059 |
| 89 | CAMK4 | 0.56590145 |
| 90 | AKT3 | 0.55745041 |
| 91 | MUSK | 0.55206384 |
| 92 | FER | 0.54993308 |
| 93 | WNK3 | 0.54953101 |
| 94 | DYRK2 | 0.54877323 |
| 95 | CSNK1D | 0.54557733 |
| 96 | STK39 | 0.53619704 |
| 97 | PRKG1 | 0.52304791 |
| 98 | RPS6KA3 | 0.51439757 |
| 99 | MAP3K1 | 0.51406404 |
| 100 | FGR | 0.51235112 |
| 101 | MET | 0.51138474 |
| 102 | PDPK1 | 0.50576979 |
| 103 | MAPKAPK5 | 0.50296494 |
| 104 | LMTK2 | 0.49055867 |
| 105 | PDK1 | 0.48559775 |
| 106 | PRKACA | 0.48503434 |
| 107 | BCR | 0.48323490 |
| 108 | PRKCA | 0.47798104 |
| 109 | MAPK10 | 0.47219094 |
| 110 | FYN | 0.45187552 |
| 111 | CSNK1A1 | 0.44982073 |
| 112 | NME1 | 0.44716397 |
| 113 | SCYL2 | 0.44446328 |
| 114 | INSRR | 0.43232736 |
| 115 | PRKCZ | 0.43113290 |
| 116 | PKN1 | 0.41998221 |
| 117 | TRIM28 | 0.40649885 |
| 118 | TAOK1 | 0.40442194 |
| 119 | GRK7 | 0.40371376 |
| 120 | MAP2K1 | 0.38477880 |
| 121 | PRKAA1 | 0.38143469 |
| 122 | PRKCB | 0.37919798 |
| 123 | MAP3K6 | 0.37800552 |
| 124 | EPHA3 | 0.37201378 |
| 125 | CDK3 | 0.36802482 |
| 126 | PRKACB | 0.33279333 |
| 127 | PRKG2 | 0.32483840 |
| 128 | ROCK2 | 0.32477682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.08611114 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29197666 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.93940508 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83661543 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.69816753 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.67659407 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.67564467 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.64280226 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62862116 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.53146708 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19171499 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.11813928 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.11085988 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10191290 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.04937950 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.88412611 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87130042 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82675942 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81680546 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.76518744 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.75564232 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.74840700 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.72637591 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57487848 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55207854 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54625322 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43540136 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35911444 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34460080 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26453841 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25867165 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.25737009 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25320216 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25215656 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.24909320 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19653085 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17234743 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12884681 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12214013 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.08401504 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.08153591 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06779405 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05647180 |
| 44 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99539873 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.98385390 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95932607 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.93588432 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93416974 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90133704 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.88502258 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87381666 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86124162 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85073224 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80318189 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80222806 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78383608 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78380972 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.77387368 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76051575 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.75892344 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74985053 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74004072 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71932650 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70230894 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69537040 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68967001 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68468503 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67152297 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63523719 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62233232 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61403760 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60521144 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60506015 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.55957570 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55620180 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55397365 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55196663 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54687977 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.54476423 |
| 80 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53927940 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52723414 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51612451 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51047750 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48637403 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47532697 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47179987 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47163768 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47038198 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46872943 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46607661 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45812928 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45788413 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.44915449 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44856935 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.44637814 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.43989079 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41013728 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39282236 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38566102 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38305909 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38223600 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38187125 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37612063 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.37290369 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37096757 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36623180 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35613088 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35509934 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35311557 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35231153 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34843922 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.34842409 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34703995 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32198640 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31592220 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31153608 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30662611 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30591878 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30388212 |
| 120 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.29033405 |
| 121 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28405445 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27439406 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27320868 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26111101 |

